Brief: Themis Medicare Issued Show Cause Notice By Regulatory Authorities - Novartis Spokesperson
July 12 (Reuters) -
* NOVARTIS INDIA LTD CLARIFIES ON REPORT ON RECALL OF
NOVARTIS'S
PAINKILLER DICLOFENAC
* THEMIS MEDICARE, MANUFACTURER OF DICLOFENAC 1 ML
INJECTION, WAS
ISSUED SHOW CAUSE NOTICE BY REGULATORY AUTHORITIES - NOVARTIS
SPOKESPERSON
* THEMIS HAS INDEPENDENTLY FILED A WRIT PETITION IN COURT
WITH
RESPECT TO ISSUE OF SHOW CAUSE NOTICE - NOVARTIS SPOKESPERSON
Further company coverage: NOIN.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Themis Medicare
See all newsBrief: Themis Medicare Gets Tax Demand Of 41.8 Million Rupees
Brief: Themis Medicare Announces Amalgamation Of Gujarat Themis Biosyn With Co
India's Themis Medicare hits record high on Q1 profit jump
Brief: Themis Medicare June-Qtr Consol Net Profit 246.8 Mln Rupees
India's Themis Medicare hits record high